benzo[d][1,3]dioxol-5-ylmethyl formate | 85262-96-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并间二氧杂环戊烯类
• 英文名称: benzo[d][1,3]dioxol-5-ylmethyl formate
• 英文别名: 1,3-Benzodioxole-5-methanol, formate；1,3-benzodioxol-5-ylmethyl formate
• CAS: 85262-96-0
• 化学式: C₉H₈O₄
• 分子量: 180.16
• InChiKey: ZPQGZTFOFQEGAF-UHFFFAOYSA-N

物化性质

• 沸点：
  283.2±9.0 °C(Predicted)
• 密度：
  1.313±0.06 g/cm3(Predicted)
• LogP：
  1.315 (est)

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  44.8
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  溴苯 、 benzo[d][1,3]dioxol-5-ylmethyl formate 在 palladium diacetate 、 1,8-二氮杂双环[5.4.0]十一碳-7-烯 、 tri tert-butylphosphoniumtetrafluoroborate 作用下， 以 邻二甲苯 为溶剂， 反应 24.0h， 以81%的产率得到benzo[d][1,3]dioxol-5-ylmethyl benzoate
  参考文献：
  名称：

  钯催化的苄基苯甲酸酯的羰基化合成，采用苄基形式作为CO替代物和苄基醇源

  摘要：

  已经开发了一种有效且方便的钯催化羰基化反应，用于从芳基溴化物合成苯甲酸苄酯。苄基甲酸酯已被研究为一种新型的高效有用的CO来源。以良好至优异的产率获得了多种苯甲酸苄酯。

  DOI：

  10.1002/ejoc.201900700
• 作为产物：
  描述：

  胡椒醇 生成 benzo[d][1,3]dioxol-5-ylmethyl formate
  参考文献：
  名称：

  Barthel; Gertler, 33-27 <1956> 1,3

  摘要：

  DOI：

文献信息

• [EN] PNA MONOMER AND PRECURSOR<br/>[FR] MONOMERE ET PRECURSEUR PNA
  申请人：PANAGENE INC

  公开号：WO2003091231A1

  公开（公告）日：2003-11-06

  This application relates to monomers of the general formula (I) for the preparation PNA (peptide nucleic acid) oligomers and provides method for the synthesis of both predefined sequence PNA oligomers and random sequence PNA oligomers: (I) wherein E is nitrogen or C-R'; J is sulfur or oxygen; R', Rl, R2, R3, R4 is independently H, halogen, alkyl, nitro, nitrile, alkoxy, halogenated alkyl, halogenated alkoxy, phenyl or halogenated phenyl, RS is H or protected or unprotected side chain of natural or unnatural a-amino acid; and B is a natural or unnatural nucleobase, wherein when said nucleobase has an exocyclic amino function, said function is protected by protecting group which is labile to acids but stable to weak to medium bases in the presence of thiol.

  该应用程序涉及通用式(I)的单体，用于制备PNA（肽核酸）寡聚体，并提供了合成预定义序列PNA寡聚体和随机序列PNA寡聚体的方法：(I)其中E为氮或C-R'; J为硫或氧; R'，Rl，R2，R3，R4独立地为H，卤素，烷基，硝基，腈基，烷氧基，卤代烷基，卤代烷氧基，苯基或卤代苯基，RS为H或天然或非天然α-氨基酸的保护或未保护侧链; B为天然或非天然核碱基，其中当所述核碱基具有外环氨基功能时，所述功能由对酸敏感但在巯基存在下对弱到中等碱稳定的保护基保护。
• PNA monomer and precursor
  申请人：——

  公开号：US20030225252A1

  公开（公告）日：2003-12-04

  This application relates to monomers of the general formula (I) for the preparation of PNA (peptide nucleic acid) oligomers and provides method for the synthesis of both predefined sequence PNA oligomers and random sequence PNA oligomers: 1 wherein E is nitrogen or C—R′; J is sulfur or oxygen; R′, R1, R2, R3, R4 is independently H, halogen, alkyl, nitro, nitrile, alkoxy, halogenated alkyl, halogenated alkoxy, phenyl or halogenated phenyl, R5 is H or protected or unprotected side chain of natural or unnatural &agr;-amino acid; and B is a natural or unnatural nucleobase, wherein when said nucleobase has an exocyclic amino function, said function is protected by protecting group which is labile to acids but stable to weak to medium bases in the presence of thiol.

  该应用程序涉及通式（I）的单体，用于制备PNA（肽核酸）寡聚体，并提供了合成预定义序列PNA寡聚体和随机序列PNA寡聚体的方法： 其中 E为氮或C—R′；J为硫或氧； R′、R1、R2、R3、R4独立地为H、卤素、烷基、硝基、腈基、烷氧基、卤代烷基、卤代烷氧基、苯基或卤代苯基， R5为H或天然或非天然α-氨基酸的保护或未保护侧链；以及 B为天然或非天然核碱基，其中当所述核碱基具有外环氨基功能时，所述功能由对酸敏感但在巯基存在下对弱到中等碱稳定的保护基保护。
• Making Carbonyls of Amides Nucleophilic and Hydroxyls of Alcohols Electrophilic Mediated by SO₂F₂ for Synthesis of Esters from Amides
  作者：Wan-Yin Fang、Gao-Feng Zha、Hua-Li Qin

  DOI：10.1021/acs.orglett.9b03274

  日期：2019.11.1

  promotion of sulfuryl fluoride, the carbonyl groups of amides performed as nucleophiles while the hydroxyl groups of alcohols were activated to functionalize as electrophiles. This study displayed that the amide C-N bonds could be easily cleaved with delicate nucleophiles to form the ester C-O bonds at room temperature without using transition metals. The broad substrate scope and excellent functional

  我们发现，随着硫酰氟的促进，酰胺的羰基作为亲核试剂发挥作用，而醇的羟基被活化以作为亲电试剂官能化。这项研究表明，在不使用过渡金属的情况下，酰胺CN键很容易被精密的亲核试剂裂解形成酯CO键。用44个实例证明了广泛的底物范围和出色的官能团相容性，产率高达99％。
• [EN] PNA MONOMER AND PRECURSOR<br/>[FR] MONOMÈRE DE PROTÉINE PNA ET PRÉCURSEUR
  申请人：PANAGENE INC

  公开号：WO2005009998A1

  公开（公告）日：2005-02-03

  This application relates to monomers of the general formula (I) for the preparation of PNA (peptide nucleic acid) oligomers and provides method for the synthesis of both predefined sequence PNA oligomers and random sequence PNA oligomers,wherein E is sulfur or oxygen; J is nitrogen or C-R'; R1, R' is independently H, halogen, alkyl, nitro, nitrile, alkoxy, halogenated alkyl, halogenated alkoxy or a functional group having one of following general formulae (A, B) wherein A1, A2, A3, A4, A5, is independently selected from H, halogen such as F, Cl, Br or I, CF3, alkyl, preferably C1,-C4 alkyl, nitro, nitrile, alkoxy, preferably C1,-C4 alkoxy, halogenated (such as F, Cl, Br and I) alkyl, preferably halogenated C1-C4 alkyl, halogenated (such as F, Cl, Br and I) alkoxy, preferably halogenated Ci-C4 alkoxy, phenyl, and halogenated (such as F, Cl, Br and I) phenyl; R2 is H or protected or unprotected side chain of natural or unnatural α-amino acid; and B is a natural or unnatural nucleobase, wherein when said nucleobase has an exocyclic amino function, said function is protected by protecting group which is labile to acids but stable to weak to medium bases in the presence of thiol.

  该应用涉及通用式(I)的单体，用于制备PNA（肽核酸）寡聚体，并提供了合成预定义序列PNA寡聚体和随机序列PNA寡聚体的方法，其中E为硫或氧；J为氮或C-R'；R1、R'独立取H、卤素、烷基、硝基、腈基、烷氧基、卤代烷基、卤代烷氧基或具有以下通用式(A、B)之一的功能基团，其中A1、A2、A3、A4、A5独立选择自H、氟、氯、溴或碘等卤素、三氟甲基、烷基，优选C1-C4烷基、硝基、腈基、烷氧基，优选C1-C4烷氧基、卤代（如氟、氯、溴和碘）烷基，优选卤代C1-C4烷基、卤代（如氟、氯、溴和碘）烷氧基，优选卤代C1-C4烷氧基，苯基和卤代（如氟、氯、溴和碘）苯基；R2为H或天然或非天然α-氨基酸的保护或未保护侧链；B为天然或非天然核碱基，其中当所述核碱基具有外环氨基功能时，所述功能由对酸敏感但在巯基存在的弱到中等碱存在下稳定的保护基团保护。
• Method of determining potential allosterically-binding matrix metalloproteinase inhibitors
  申请人：Andrianjara Charles

  公开号：US20050004126A1

  公开（公告）日：2005-01-06

  Compounds are provided that bind allosterically to the catalytic domain of MMP-13 and comprise a hydrophobic group, first and second hydrogen bond acceptors and at least one, and preferably both, of a third hydrogen bond acceptor and a second hydrophobic group. Cartesian coordinates for centroids of the above features are defined in the specification. When the ligand binds to MMP-13, the first, second and third (when present) hydrogen bond acceptors bond respectively with Thr245, Thr 247 and Met 253, the first hydrophobic group locates within the S1′ channel of MMP-13 and the second hydrophobic group (when present) is relatively open to solvent. The compounds specifically inhibit the matrix metalloproteinase-13 enzyme and thus are useful for treating diseases resulting from tissue breakdown, such as heart disease, multiple sclerosis, arthritis, atherosclerosis, and osteoporosis.

  提供了一种与MMP-13催化域发生变构作用的化合物，其中包括一个疏水基团、第一和第二氢键受体以及至少一个第三氢键受体和第二个疏水基团，最好是两者都有。上述特征的笛卡尔坐标在说明书中有定义。当配体与MMP-13结合时，第一、第二和第三（存在时）氢键受体分别与Thr245、Thr 247和Met 253结合，第一疏水基团位于MMP-13的S1'通道内，第二疏水基团（存在时）相对于溶剂较为开放。这些化合物特异性地抑制了基质金属蛋白酶-13酶，因此可用于治疗由组织分解引起的疾病，如心脏病、多发性硬化症、关节炎、动脉粥样硬化和骨质疏松症。